IL23A and neoplasm: We found that the mRNA of TTP was significantly higher in vvDD-IL-23A-treated tumor cells (Figure 6B) or tumor tissue (Figure 6C) compared with vvDD-IL-23-treated tumor cells (Figure 6B) or tumor tissue (Figure 6C), indicating that TTP may negatively impact the IL-23A mRNA stability after vvDD-IL-23A infection, preventing its pro-tumor or antitumor activity (Figure 6D).